Myriad Genetics (NASDAQ:MYGN) Shares Gap Down After Insider Selling themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (NASDAQ:MYGN – Get Free Report) updated its FY23 earnings guidance on Monday. The company provided EPS guidance of ($0.33)-($0.28) for the period, compared to the consensus EPS estimate of ($0.32). The company issued revenue guidance of $747-$753 million, compared to the consensus revenue estimate of $739.22 million. Myriad Genetics Stock Down 4.0 % […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.05, Briefing.com reports. The company had revenue of $191.90 million for the quarter, compared to analysts’ expectations of $179.23 million. Myriad Genetics had a […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective decreased by equities researchers at JPMorgan Chase & Co. from $17.00 to $14.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 21.30% […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. Several other analysts also recently issued reports on MYGN. JPMorgan Chase & Co. decreased their target price on Myriad Genetics from $18.00 to $17.00 and […]